Actively Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
Led by Mount Sinai Hospital, Canada · Updated on 2025-03-25
150
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
Sponsors
M
Mount Sinai Hospital, Canada
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.
CONDITIONS
Official Title
Genome Analysis Across Populations in Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with inflammatory bowel disease (Crohn's disease, ulcerative colitis, or IBD-undetermined)
- Medical records available to confirm IBD diagnosis
- Healthy controls have no personal or family history of IBD
- Healthy controls have no history of unexplained chronic diarrhea, blood in stool, anemia, abdominal pain, or weight loss
- Participants of any age are eligible
You will not qualify if you...
- Having gastrointestinal conditions other than IBD or healthy control criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sinai Health System
Toronto, Ontario, Canada, M5G 1X5
Actively Recruiting
Research Team
J
Joanne Stempak, MSc
CONTACT
J
Jenny Lee, MKin
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here